Emisphere Technologies, Inc. (EMIS.OB)
1.04USD
11:00am EST
$-0.02 (-1.89%)
$1.06
$1.04
$1.04
$1.04
800
84,483
$1.49
$0.42
EMIS.OB
About
Overall
| Beta: | 1.78 |
| Market Cap (Mil.): | $44.59 |
| Shares Outstanding (Mil.): | 42.07 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| EMIS.OB | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 11.65 | 3.76 |
| EPS (TTM): | -0.77 | -- | -- |
| ROI: | -- | 1.47 | 2.30 |
| ROE: | -- | 2.41 | 2.82 |
UPDATE 1-Novo starts tests on pill version of Victoza drug
* Partner Emisphere earns $2 mln from start of UK study
UPDATE 1-Icahn fund discloses stakes in Yahoo, Motorola
WASHINGTON, Aug 14 (Reuters) - Billionaire investor Carl Icahn reported on Thursday that he owned 55 million shares in Yahoo Inc as of June 30 and that he had increased his stake in Motorola Inc to 144.1 million shares from 115.6 million shares the prior quarter.
Emisphere Technologies Q3 results
EMISPHERE TECHNOLOGIES INC : * Third quarter earnings per share $0.10 * Third quarter diluted earnings per share $0.09 * Says third quarter includes net proceeds from the settlement of lawsuit of $11.9 million * Reuters Estimates third quarter earnings per share view $-0.14
UPDATE 1-Emisphere wins $18 million in Lilly settlement
NEW YORK, Sept 25 (Reuters) - Emisphere Technologies Inc said on Tuesday that it had agreed to settle litigation with Eli Lilly and Co , its former partner in a drug-development deal, for $18 million.
Emisphere to get $18 mln from Eli Lilly to settle litigation
Sept 25 (Reuters) - Emisphere Technologies Inc said it agreed to settle a pending litigation with Eli Lilly and Co for $18 million.
Emisphere names new CFO
Aug 29 (Reuters) - Biopharmaceutical company Emisphere Technologies Inc named Michael Garone as its chief financial officer.
TABLE-Emisphere Q2 loss widens
EMISPHERE TECHNOLOGIES INC. (In $) Latest Yr ago qtr Loss/shr (diluted) 0.43 0.14 Net loss (million) 12.1 3.8 Revenue (thousands) 398 5,220 Reuters Estimates: Loss/shr $0.28 (one analyst) (Reporting by Sreerupa Mitra in Bangalore)
Competitors
| Price | Change | |
|---|---|---|
| Eli Lilly & Co. (LLY.N) | $34.07 | -0.64 |
| Unigene Laboratories (UGNE.OB) | $0.58 | -0.01 |
| GlaxoSmithKline plc (GSK.L) | £1,196.50 | -22.00 |
| Novartis AG (NOVN.VX) | CHF56.70 | -0.10 |
| Amylin Pharmaceuticals, Inc. (AMLN.OQ) | $17.22 | -0.21 |
| Novo Nordisk A/S (NOVOb.CO) | kr.375.00 | -0.30 |
| Sanofi-Aventis SA (SASY.PA) | €51.86 | -0.80 |
| Bristol Myers Squibb Co. (BMY.N) | $23.83 | -0.42 |
| Bristol Myers Squibb Co. (BMY_p.N) | $439.50 | 0.00 |
| Biocon Limited (BION.BO) | Rs258.25 | -3.95 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
